Virtu Financial LLC Medicenna Therapeutics Corp. Transaction History

Virtu Financial LLC

  • $1.43 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$0.28 - $0.51 $2,644 - $4,816
-9,444 Reduced 43.86%
12,086 $3,000
Q2 2023

Jul 27, 2023
BUY
$0.44 - $0.82 $9,473 - $17,654
21,530 New
21,530 $10,000
Q4 2022

Feb 15, 2023
BUY
$0.4 - $0.68 $17,196 - $29,233
42,990 New
42,990 $20,000

Others Institutions Holding MDNA

# of Institutions
3
Shares Held
863K
Call Options Held
0
Put Options Held
0
View Full List

About Medicenna Therapeutics Corp.

MDNA Quotes by TradingView
  • Ticker MDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,637,504
  • Market Cap $21.6M
  • Description
  • Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase IIb clinical trial for the treatment of recurrent glioblastoma, as well as...
More about MDNA
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email